Taking vitamin D with healthy fats may boost absorption, helping your body get more from every daily supplement.

SOLARIS (Alliance A021703), a multicenter, double-blind, randomized Phase III clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several hundred cancer centers in the ...

For patients with metastatic colorectal cancer, adding a higher dose proves just as effective as the standard dose of vitamin D3, despite one exception. In patients with metastatic (spreading) ...

Using significantly higher doses of vitamin D than recommended for five years did not affect the incidence of type 2 diabetes in elderly men and women, according to a new study from the University of ...

Tailoring vitamin D3 doses according to patient needs following a heart attack reduces the risk of a second heart attack by 50%. The corresponding study was presented at the 2025 American Heart ...

Vitamin D is one of the most widely used supplements in the United States, yet it is also one of the easiest to take ...

Study title: SOLARIS (Alliance A021703): A multicenter double-blind phase III randomized clinical trial of vitamin D combined with standard chemotherapy plus bevacizumab in patients with previously ...

Vitamin D is one of the most popular supplements in the United States, yet many people take it incorrectly without realizing ...

Long-term daily supplementation with moderate (1600 international units [IU]) or high (3200 IU) doses of vitamin D3 doesn’t reduce the risk for type 2 diabetes (T2D) among generally healthy older ...

It can be easy to think you get plenty of vitamin D when you live in a country bathed in sunshine, but the reality is more ...

High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduced disease activity in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) in the ...

A double-blind randomized phase 3 clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several hundred cancer centers in the U.S. tested the addition of high-dose ...